Maxine Vaccine celebrates a biotech breakthrough that shows imaginative branding as well as medical commitment.

Maxine Vaccine considers the motives of politicians, clinicians and the pharmaceutical industry and concludes that no matter what direction you approach it from, health is never a simple issue.

Maxine Vaccine examines the lessons of a preventable death for doctors and the healthcare industry, and asks whether the true barriers to integrated care are cultural rather than economic.

Maxine Vaccine pays tribute to the genius of Vidal Sassoon and gives five reasons why the legendary hairdresser is a role model for medical sales professionals.

The UK Government has decreed the risks of NHS reform to be a state secret. Maxine Vaccine looks at what the veto on publication of the NHS transition risk register is covering up.

The erectile dysfunction drug market is shaped by the parallel needs of consumers and industry, with both demanding faster and more reliable performance. Maxine Vaccine explores the fine line between medicine and desire.

As the industry adjusts to life after the patent cliff, Maxine Vaccine suggests it may be time to abandon the ‘blockbuster’ mentality and look to a new model of integrated care.

Pf Editor Chris Ross highlights the importance of understanding the needs of customers following the fall out from the Health and Social Care Bill.

The US government thinks pharmaceutical sales reps are not selling, but rather promoting. Maxine Vaccine asks whether the pharma industry could do itself a favour by agreeing.

Pipeline or P45? Blogger Maxine Vaccine asks whether the pharma industry is willing to put its money where its mouth is regarding its strategy for surviving the recession.